Emma Louise Klatman

TL;DR: Global access to blood glucose meters and test strips should be viewed similarly to essential medicines, with issues of access prioritised by relevant international agencies, and efforts are needed to reduce tariffs and taxes and to create unified global system accuracy requirements and accountable post-marketing evaluations.

TL;DR: A WHO framework developed to assess progress towards UHC is demonstrated which could be developed as a means of tracking progress in meeting the needs of people with diabetes, and the utility of this framework is demonstrated.

TL;DR: The authors of this commentary are involved in the care of T1D in LMICs and see services in such settings suffering in three major ways from the impacts of COVID-19, including the immediate impact of lockdowns and restrictions on international transport; the need for accurate information for patients, carers and health professionals; and the medium-to long-term impacts on health budgets.

TL;DR: There are substantial gaps in care for diabetes in all low-resource settings, not only in humanitarian crises, and that many other NCDs (eg, cardiovascular disease, chronic obstructive pulmonary disease, and asthma) are also prevalent globally and inadequately addressed in humanitarian settings.